Skip to content Skip to left sidebar Skip to footer

Author: Rishi Sharma

Reminder: Update Patient Contact Information

Help Us Improve the Patient Portal

Dear Providers, 

This is a reminder that the Immunization Program will soon be launching a patient portal where residents can easily access their immunization record, including their COVID-19 immunization record. This record can be used for entry into restaurants, theaters, schools, planes, and more. In order to offer this resource, PhilaVax records need to be up-to-date with each patient’s phone number and email address. Please ensure that the patient information in your electronic health record (EHR), including phone number and email address, is up-to-date when patients seek care at your facility. This information feeds directly into PhilaVax records and will be used by residents to access the patient portal. Without up-to-date information, patients will be unable to access the PhilaVax patient portal.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

Action Required: User Re-Enrollment

Action Required: User Re-Enrollment

Dear PhilaVax Users,

PDPH is currently undergoing annual user re-enrollment.

All users must complete the confidentiality agreement for the 2022 calendar year for continued access to PhilaVax. 
All agreements must be completed by February 7, 2022. User accounts without an updated agreement by this date will be rendered inactive until the agreement is completed.

You can find the form at the button below. 

COVID-19 Booster Recommendations

COVID-19 Booster Recommendations

COVID-19 boosters help protect our communities against the virus. The CDC recently announced its recommendation that everyone ages 16 and older should get a booster when possible.

Read below for a reminder of booster recommendations for your patients.

Those who received Pfizer-BioNTech or Moderna should:
Get a booster at least 6 months after completing the primary COVID-19 vaccination series. 16 and 17-year-olds are only approved for Pfizer boosters. For everyone 18+, a “mix and match” approach to booster shots has been approved, so either Pfizer or Moderna boosters are recommended.

Those who received Johnson & Johnson’s Janssen should:
Get a booster at least 2 months after completing your primary COVID-19 vaccination. Pfizer or Moderna boosters are recommended.

For those who received a COVID-19 vaccine outside the United States:
• People who were vaccinated outside the United States with a single dose or 2-dose primary series of a currently FDA-approved or FDA-authorized COVID-19 vaccine are considered fully vaccinated and should receive a booster.
• People who are moderately or severely immunocompromised and were vaccinated with a 2-dose mRNA COVID-19 vaccine primary series should receive an additional primary dose before receiving a booster.
• If they received the first dose of a 2-dose mRNA COVID-19 vaccine series, they do not need to restart the vaccine series in the United States. They should receive the second dose as close to the recommended time as possible and are considered fully vaccinated upon completion of the 2-dose primary series.
• If they received a COVID-19 vaccine not approved or authorized by the FDA, they should be offered primary vaccination with an FDA-approved or authorized vaccine before receiving a booster.

View more information about COVID vaccinations outside the country.

If you have any additional questions, view the full CDC booster guidelines or email vaccines@phila.gov.

Pfizer “Tris Product” Shelf-Life Extension

Pfizer “Tris Product” Shelf-Life Extension

FDA has approved a shelf-life extension for the Pfizer Pediatric vaccine (orange cap, 5-11 years old, diluent required) and the soon-to-be available Adol/Adult Tris (gray cap, age 12+, no diluent). The expiration date for Pfizer orange and gray cap vaccine has now been extended to 9 months (while held at ULT, or ultra-low temperatures). This approval takes effect immediately. This extension applies to frozen, ultra-low temperature (ULT) inventories only.

Details about this extension may be found in the updated facts sheets, accessible here: Healthcare Providers for 5-11 years of age, orange cap (must dilute); Healthcare Providers for 12 years of age and older, gray cap (no dilution). The Fact Sheets for both orange and gray cap vials provided by the FDA now reads, “regardless of storage conditions, vaccines should not be used after 9 months from the date of manufacture printed on the vial and cartons.”

As you are aware, the date printed on the Pfizer Pediatric (orange cap) and Adult/Adolescent (gray cap, 12+, no diluent) vaccine vials indicate the manufacture date and NOT the expiration date. The updated expiry dates for both the orange and gray cap vials based on 9 months from the date of manufacture are provided below.

The QR code provided on the Pfizer Pediatric Vaccine carton provides a link to the EUA but does not provide information on expiration dates.

Please follow EUA recommendations for storage:

Pfizer Pediatric vaccine (orange cap, 5-11 years old, diluent required):
• If not previously thawed at 2ºC to 8ºC (35ºF to 46ºF), allow vials to thaw at room temperature [up to 25ºC (77ºF)] for 30 minutes.
• Pfizer-BioNTech COVID-19 vaccine multiple dose vials with orange caps and labels with orange borders may be stored at room temperature [8°C to 25°C (46°F to 77°F)] for a total of 12 hours prior to dilution.
• After dilution, the vial should be held between 2ºC to 25°C (35°F to 77°F). Vials should be discarded 12 hours after dilution.

Adol/Adult Tris (gray cap, age 12+, no diluent) formulation:
• Frozen vials may be stored in an ultra-low temperature freezer at -90ºC to -60ºC (-130ºF to -76ºF). Do not store vials at -25°C to -15°C (-13°F to 5°F). Once vials are thawed, they should not be refrozen.
• Vials may be transferred to the refrigerator [2ºC to 8ºC (35ºF to 46ºF)], thawed and stored for up to 10 weeks. The 10-week refrigerated expiry date should be recorded on the carton at the time of transfer. A carton of 10 vials may take up to 6 hours to thaw at this temperature.

Regardless of storage condition, vaccines should not be used after 9 months from the date of manufacture printed on the vial and cartons.

All Pfizer updated Fact Sheets may be found using the following links:

Pfizer-BioNTech Fact Sheets (English) and FAQs

Provider Fact Sheet: 5-11 years of age, orange cap (must dilute)

Provider Fact Sheet: 12 years of age and older, gray cap (no dilution)

Notice: Upcoming User Re-Enrollment

Notice: Upcoming User Re-Enrollment

Dear PhilaVax Users,

PDPH is currently preparing for annual user re-enrollment. In preparation for this enrollment, no new user accounts will be issued until January 3, 2022.

Users must complete the confidentiality agreement for the 2022 calendar year.

You can find the form at the button below when re-enrollment begins on January 3.

Upcoming COVID-19 Vaccine Ordering Changes

Upcoming COVID-19 Vaccine Ordering Changes

Due to the holiday, COVID-19 vaccine orders are due on Mondays at 5pm for the next two weeks (the week of the 20th and the 27th). Please submit your upcoming orders by Monday at 5pm instead of Wednesday in order for them to be processed.

For assistance with submitting your order, email:

Provider Education Coordinator
DPHProviderhelp@phila.gov

Vaccine Order Specialist
Christine Wilson
Christine.Wilson@phila.gov

Vaccine Order Specialist
Charma Miller
Charma.Miller@phila.gov